European Medicines Agency (EMA)
The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam. It began operating in 1995. It is responsible for the scientific evaluation, supervision and safety monitoring of medicines in the EU.
This traineeship opportunity is now open for applications until 06 May 2026 23:59 CET, with an intake on 1 October 2026.
About the traineeship programme
The Agency is looking for motivated, qualified recent graduates or students on an Erasmus+ or other programme or PhD students or Master’s students (who posses a previous degree), who are interested in gaining experience and contribute to the Agency’s work for every patient in Europe. The purpose of a traineeship at the Agency is to perform tasks that are predominantly in the interest of the trainee’s training and principally serve to increase the trainee’s knowledge and to gain relevant experience.
Placement description
We are looking for a trainee in the Pharmaceutical Quality Office.
Specific objectives and projects
Context
As environmental sustainability becomes increasingly important, the pharmaceutical sector faces growing expectations to design, develop, manufacture and manage medicinal products with sustainability in mind. The EU and the European medicines regulatory network have identified environmental sustainability as a key objective in their recent strategy documents.
The European Medicines Agency supports innovation aimed at implementing more sustainable manufacturing approaches through the work of the Quality Innovation Group and the development of guidance in areas such as F-gas replacements, continuous manufacturing and other quality aspects (e.g. packaging) that may have an impact on environmental sustainability.
Project tasks
- map and analyse green manufacturing approaches described in marketing authorisation applications (MAA) and lifecycle submissions;
- identify trends and regulatory challenges that applicants face in MAA and lifecycle submissions related to green manufacturing;
- identify areas where future guidance may be needed to support the implementation of sustainable manufacturing approaches, and contribute proposals for consideration within the BWP, QWP and QIG work planning;
- contribute to the preparation of Q&As, where relevant.
Learning outcomes
By the end of the traineeship, the trainee will:
- develop knowledge of the regulatory framework supporting innovation in the development and manufacture of human medicines;
- gain insight into EU legislation related to environmental sustainability;
- gain practical experience working with the Quality Innovation Group and the European regulatory network and expert groups;
- gain insight into how marketing authorisation applications are evaluated at EMA.
Meer informatie/solliciteren: careers.ema.europa.eu.